Co-Dispensing of Benzodiazepines and Opioids Dangerous in HD
Patients on hemodialysis who use opioids concurrently with a short-acting benzodiazepine are especially at risk for early death, a study found.
Hemodialysis
Nearly 40% of This Nephrologist’s ESKD Patients Dialyze at Home
Shaminder Gupta, MD, is a nephrologist who practices in Houma, Louisiana. He serves as the section chief at his hospital and also as Corporate Medical Director at Monogram Health, a renal disease care management company. He tells Renal & Urology News how he developed and manages a home dialysis program in which approximately 40% of his patients…
Vadadustat Noninferior to Darbepoetin Alfa for Anemia in Patients With Dialysis-Dependent CKD
The studies compared the efficacy and safety of vadadustat to darbepoetin alfa in adult patients on dialysis with anemia due to CKD.
SGLT2 Inhibitors Linked With Lower Risk for Serious Renal Events
Study findings further support the use of SGLT2 inhibitors in a broad range of patients with type 2 diabetes, according to investigators.
Twice-Weekly Hemodialysis Suggested for COVID-19 Risk Reduction
The authors of a recent editorial present a case for considering twice-weekly rather than the standard thrice-week hemodialysis, a shift that can reduce exposure to the COVID-19 coronavirus, conserve personal protective equipment and other benefits.
COVID-19 Crisis Could Speed Adoption of Home Dialysis
Patients on dialysis are at especially high risk of infection and experiencing severe complications of infection. The pandemic may prompt patients and their physicians to consider the benefits of dialyzing at home.
Kidney Function Recovery Patterns After AKI Predict Long-Term Risks
Clinicians managing patients with AKI should consider the severity of the disease as well as its course, according to researchers.
High-Dose vs Low-Dose IV Iron Does Not Raise Infection Risk in Hemodialysis Patients
Patients on hemodialysis who received high-dose had similar rates of infection and rates of hospitalization for infection compared with those treated with low-dose IV iron, a secondary analysis of the PIVOTAL trial revealed.
Dialysis Industry Unites in Wake of COVID-19 Pandemic
DaVita Inc. and Fresenius Medical Care North America (FMCNA) jointly announced they are collaborating in response to the COVID-19 pandemic to offer isolation capacity for dialysis patients who are or may be infected with the novel coronavirus that causes the disease. The companies, which are the largest providers of dialysis in the United States, also…
COVID-19 Surfaces in a US Hemodialysis Patient
Physicians at the University of California Irvine describe an unusual presentation of the novel coronavirus illness in a 56-year-old man. The case is believed to be among the first COVID-19 cases in the United States.
-
Loading...
-
Loading...
Next post in Hemodialysis
